Garmpis, N.; Damaskos, C.; Dimitroulis, D.; Kouraklis, G.; Garmpi, A.; Sarantis, P.; Koustas, E.; Patsouras, A.; Psilopatis, I.; Antoniou, E.A.;
et al. Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer. J. Pers. Med. 2022, 12, 1672.
https://doi.org/10.3390/jpm12101672
AMA Style
Garmpis N, Damaskos C, Dimitroulis D, Kouraklis G, Garmpi A, Sarantis P, Koustas E, Patsouras A, Psilopatis I, Antoniou EA,
et al. Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer. Journal of Personalized Medicine. 2022; 12(10):1672.
https://doi.org/10.3390/jpm12101672
Chicago/Turabian Style
Garmpis, Nikolaos, Christos Damaskos, Dimitrios Dimitroulis, Gregory Kouraklis, Anna Garmpi, Panagiotis Sarantis, Evangelos Koustas, Alexandros Patsouras, Iason Psilopatis, Efstathios A. Antoniou,
and et al. 2022. "Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer" Journal of Personalized Medicine 12, no. 10: 1672.
https://doi.org/10.3390/jpm12101672
APA Style
Garmpis, N., Damaskos, C., Dimitroulis, D., Kouraklis, G., Garmpi, A., Sarantis, P., Koustas, E., Patsouras, A., Psilopatis, I., Antoniou, E. A., Karamouzis, M. V., Kontzoglou, K., & Nonni, A.
(2022). Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer. Journal of Personalized Medicine, 12(10), 1672.
https://doi.org/10.3390/jpm12101672